The controllers ordered the removal of the active substance valsartan, which may be impurities in the drug



[ad_1]

BRATISLAVA, July 4 (WebNoviny.sk) – The State Institute for Drug Control (SÚKL) has ordered the withdrawal of drugs containing the active ingredient valsartan from distribution companies and pharmacies [19659002] How to inform the Institute in a press release there is suspicion of a lack of quality – perhaps the presence of undeclared impurities in the active substance

Drugs with active substance valsartan are used to treat high blood pressure, treat a recent heart attack, and treat symptomatic heart failure

Patients should seek medical advice

"Because patients are taking medications given no acute risk is present, abrupt discontinuation of treatment is not recommended.However, it is essential that these patients consult their treating physician within a reasonable time period. of one month, who will prescribe another appropriate treatment.Many therapeutic remedies are available in the Slovak market, so that the treatment of patients is not compromised. " explained the Institute

  Nurses, hospital

Medicines evolve at the pan-European level The lack of quality is shared by the European Medicines Agency aments (EMA) and the European Quality Management Agency (EDQM). The Authority will consider, in addition to other medicinal products containing the active substance valsartan, medicinal products containing other products of comparable chemical structure

Lot of conflicting medicinal products

The decision concerns the following lots: VAPRESS 160mg, tbl fm 28 × 160mg (blis.PVC / PE / PVDC / Al), VAPRESS 160mg, tbl fm 90x160mg (blis.PVC / PE / PVDC / Al), VAPRESS 80mg, tbl fm 28 × 80 mg PVDC / Al), Vasopentol HCT 80 / 12.5 mg, tbl / ml 30 x 80 mg / 12.5 mg (blis.PVC / PE / PVDC / Al), Vasopentol HCT 160 / 12.5 mg, tbl 30 × 160 mg / 12.5 mg (blis.PVC / PE / PVDC / Al), Vasopentol HCT 160 / 12.5 mg, tblfm 98 × 160 mg / 12.5 mg (blis.PVC / PE / PVDC / Al), Vasopentol HCT 160/25 mg, tbl flm 30 × 160 mg / 25 mg (blis.PVC / PE / PVDC / Al)

  drops, drops, eye drops, eyes

In addition, the following are lot: Vasopentol HCT 160/25 mg, Vasopentol 80 mg, tbl flm 30 mg / ml (blis.PVC / PE / PVDC / × 80 mg / ml (blis.PVC / PE / PVDC-Al), Vasopentol 160 mg, tblmax 30 x 160 mg (blis.PVC / PE / PVDC-Al) PE / PVDC / Al), Valzap 160mg, tbl fm 28x160mg (blis.PVC / PE / PVDC / Al), Valzap 160mg, tbl fm 84x160mg (blis.PVC / PE / PVDC / Al), Valzap HCT 160mg / 12 , 5mg, 28mg / 160mg / 12.5mg (blis.PVC / PE PVDC / Al), Valzap HCT 160mg / 12.5mg, tblfm 84x160mg / 12.5mg (blind. PVC / PE / PVDC / Al), Valzap HCT 160mg / 25mg, × 160mg / 25mg (blis.PVC / PE / PVDC / Al), Valsartan HCT Actavis 160/25mg, tbl fm 28 × 160mg / 25mg (blis.PVC / PE / 160 / 12.5mg, tbl fm 28x160mg / 12.5mg (blis.PVC / PE / PVDC / Al), Valsartan HCT Actavis 160 / 12.5mg, tbl 98 x 160 mg / 12.5 mg (blis.PVC / PE / PVDC / Al), Valsartan Actavis 80 mg, tblfm 28 × 80 mg (blis.PVC / PE / PVDC / Al), Valsartan Actavis 160 mg, tbl flm 28 × 160 mg (bl. PVC / PE / PVDC / Al), Valsartan Actavis 160 mg, tbl fmax 98 x 160 mg (blis.PVC / PE / PVDC / Al) 59016] window.fbAsyncInit = function () {
FB.init ({
appId: '641384982725541',
xfbml: true,
version: & # 39; v2.8 & # 39;
});
};

(function (d, s, id) {
var js, fjs = d.getElementsByTagName (s) [0];
if (d.getElementById (id)) {
return;
}
js = d.createElement (s);
js.id = id;
js.src = "http://connect.facebook.net/en_US/all.js";
fjs.parentNode.insertBefore (js, fjs);
} (document, 'script', 'facebook-jssdk'));
[ad_2]
Source link